2024 International Congress

September 27-October 1, 2024. Philadelphia, PA.

View by Title View Sessions

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Long-Term Safety and Efficacy of Foscarbidopa/Foslevodopa in Patients with Advanced Parkinson’s Disease: Results From an Ongoing Phase 3 Open-Label Extension with Up to 1 Year Follow-Up

R. Hauser, V. Fung, T. Kimber, K. Klos, M. Facheris, A. Jeong, J. Jia, A. Spiegel, M. Soileau (Tampa, USA)
Long-term Safety of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension

R. Freeman, I. Biaggioni, R. Vickery, L. Norcliffe-Kaufmann, T. Guerin, M. Bryarly, V. Iodice, M. Rudzniska-Bar, M. Boczarska-Jedynak, C. Oehlwein, C. Shibao, H. Kaufmann (Boston, USA)
Longevity of Motor Benefit Achieved with Deep Brain Stimulation (DBS) of the Subthalamic Nucleus (STN) in a Single Center Cohort at the Decade Mark Post-Implantation.

D. Caputo, R. Dipaola, S. Danish, E. Hargreaves (Neptune, USA)
Longitudinal Analysis of fragile X-associated tremor/ataxia syndrome Progression: A One-Year Follow-Up of 24 Patients

M. Tosin, D. Hall, L. Quinchia (Chicago, USA)
Longitudinal Assessment of Dystonic Symptoms in Rapid-Onset Dystonia-Parkinsonism: genetic dystonia symptoms vary over time

I. Haq, V. Wheelock, L. Ozelius, B. Snively, E. Napoli, K. Sweadner, A. Brashear (Miami, USA)
Longitudinal change in brain function and structure related to plasma neurofilament light protein in early-stage Parkinson’s disease

Y. Xiao, SC. Wang, YB. Hou, HF. Shang (Chengdu, China)
Longitudinal Changes in Quality of Life After Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease

T. Yamamoto, Y. Yamanaka, S. Hirano, A. Sugiyama, N. Araki, Y. Higuchi, S. Kuwabara (Chiba, Japan)
Longitudinal Gait Speed Analysis at Prodromal and Early Stage of Parkinson’s Disease

S. Sambin, M. Houot, F. Khoury, G. Mangone, L-L. Mariani, I. Arnulf, S. Lehericy, M. Vidailhet, J-C. Corvol (Paris, France)
Longitudinal patterns of Anxiety and Depression in patients with Parkinson’s Disease

O. Lawal, M. Morales, S. Shakya, J. Savitt, S. Reich, A. Gruber-Baldini, L. Shulman, R. von Coelln (Baltimore, USA)
Longitudinal progress and clinical relevance of 18F-Florzolutau PET in patients with PSP: a one-year follow-up study

J. Wang, F. Liu, C. Zuo (Shanghai, China)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z